Skip to main content
Premium Trial:

Request an Annual Quote

AltheaDx Teams with Institute on Pediatric Cancer MDx

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AltheaDx today said that it will collaborate with the Nicholas Conor Institute for Pediatric Cancer Research on developing molecular diagnostic tests for pediatric cancer.

The San Diego-based firm, which is developing microarray-based genetic tests, said that the collaboration will upon its existing test for diagnosis of multiple pediatric tumor types, and expand the test beyond diagnosis to prognosis and therapeutic monitoring. It said that the goal of the alliance is to create a single genetic panel from a single biopsy that will diagnose and inform treatment.

The Nicholas Conor Institute is a San Diego-based non-profit focused on finding new diagnostics and treatments for pediatric cancer.

The partners noted that they are currently seeking funding to cover the development costs of the program.

As reported last week by GenomeWeb Daily News, AltheaDx recently raised $6 million in a Series A round of equity financing.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.